Gwenn Hansen sold $143K of NRIX stock

Gwenn Hansen, Chief Scientific Officer of Nurix Therapeutics, Inc. (NRIX), sold 5,409 shares of NRIX stock worth $143K, per an SEC Form 4 filed Nov 3, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 30, 2026, 4 days before it was made public.

NRIX has moved -42.9% since the trade date, from $26.80 to $15.30 (Nov 6, 2026 close).